OCI shares can be purchased through a stockbroker, financial adviser, bank or share-dealing platform.
Financial calendar
The announcement and publication of the Company’s results is expected in the months shown below:
January | Publication of Q4 2025 trading update |
|---|---|
March | Final results for the year announced, Annual Report published |
April | Publication of Q1 2026 trading update |
May | Capital Markets Day |
July | Publication of Q2 2026 trading update |
September | Interim results announced, Interim Report published, AGM |
October | Publication of Q3 2026 trading update |
Share dealing
Investors wishing to purchase or sell shares in the Company may do so through a stockbroker, financial adviser, bank or share-dealing platform. To purchase this investment, you should read the Key Information Document (‘KID’) before buying or selling shares in the Company.
Share buybacks and dividend
During the year, the Board cancelled any future OCI dividends and launched an annual share buyback programme, initially of a minimum of £20 million. The 2025 buyback programme was subsequently increased to £50 million, reflecting the assessment of current liquidity and the improved prospects for proceeds. During the year, £48 million of shares were repurchased, increasing the total value of shares acquired and cancelled since 2019 to £120 million. On 8 January 2026, OCI completed its 2025 buyback programme, having acquired and cancelled c.9.7 million shares (2024: nil) for an aggregate £50 million (2024: nil), and generating a NAV per share gain of 11 pence (2024: nil) over the course of the programme.
Important information
Past performance is not a reliable indicator of future results. There is an inherent risk in investing, with no guaranteed return on any investments made. The value of OCI shares can fall as well as rise and you may get back less than you invested when you decide to sell your shares.
Rights attaching to shares
The rights attaching to shares are set out in the bye-laws of the Company. All or any of the special rights for the time being attached to the shares or any class of shares may be varied, modified or abrogated either with the consent in writing of the shareholders of not less than three-fourths of the issued shares of that class or with the sanction of a special resolution passed at a separate general meeting of the holders of the shares of that class. There are no restrictions on the transfer of ordinary shares other than those which may be imposed by law from time to time. There are no special control rights in relation to the Company’s shares and the Company is not aware of any agreements between holders of securities that may result in restrictions on the transfer of securities or on voting rights. In accordance with the Market Abuse Regulation and the Company’s share dealing code, Board members and certain employees of the Company’s service providers are required to seek approval to deal in the Company’s shares.
At a general meeting of the Company, every holder of shares who is present in person or by proxy shall, on a poll, have one vote for every share of which they are the holder.
All the rights attached to a treasury share1 shall be suspended and shall not be exercised by the Company while it holds such treasury shares and, where required by the Act, all treasury shares shall be excluded from the calculation of any percentage or fraction of the share capital or shares of the Company. As at 31 December 2025, the Company did not hold any treasury shares.
1. A share of the Company that was or is treated as having been acquired and held by the Company and has been held continuously by the Company since it was so acquired and has not been cancelled.